Reply to comment on Cost of poor adherence to anti-hypertensive therapy in five European country

F S Mennini^{1

2}, Andrea Marcellusi^{3

4}, J M Graf von der Schulenburg⁵, A Gray⁶, P Levy⁷, P Sciattella¹, M Soro⁸, G Staffiero⁹, J Zeidler⁵, A Maggioni¹⁰, R E Schmieder¹¹

Affiliations

¹ Economic Evaluation and HTA (EEHTA) CEIS, Faculty of Economics, University of Rome "Tor Vergata", Via Columbia 2, 00133, Rome, Italy.
² Institute for Leadership and Management, Kingston University, London, UK.
³ Economic Evaluation and HTA (EEHTA) CEIS, Faculty of Economics, University of Rome "Tor Vergata", Via Columbia 2, 00133, Rome, Italy. andrea.marcellusi@uniroma2.it.
⁴ Department of Demography, University of Rome "La Sapienza", Rome, Italy. andrea.marcellusi@uniroma2.it.
⁵ Center for Health Economics Research Hannover (CHERH), Leibniz Universität Hannover, Hannover, Germany.
⁶ Department of Public Health, Health Economics Research Centre, University of Oxford, Oxford, UK.
⁷ PSL, Université Paris-Dauphine, LEDa-LEGOS, 75016, Paris, France.
⁸ Market Access Deptartment, Daiichi Sankyo Europe, Munich, Germany.
⁹ Department of Economics and Business, CRES, Universitat Pompeu Fabra Barcelona, Barcelona, Spain.
¹⁰ Associazione Nazionale Medici Cardiologi Ospedalieri Research Center, Florence, Italy.
¹¹ Department of Nephrology and Hypertension, University Hospital Erlangen, Erlangen, Germany.

Comment

F S Mennini et al. Eur J Health Econ. 2015 Nov.

. 2015 Nov;16(8):909-11.

doi: 10.1007/s10198-015-0712-y.

F S Mennini^{1

2}, Andrea Marcellusi^{3

4}, J M Graf von der Schulenburg⁵, A Gray⁶, P Levy⁷, P Sciattella¹, M Soro⁸, G Staffiero⁹, J Zeidler⁵, A Maggioni¹⁰, R E Schmieder¹¹

¹ Economic Evaluation and HTA (EEHTA) CEIS, Faculty of Economics, University of Rome "Tor Vergata", Via Columbia 2, 00133, Rome, Italy.
² Institute for Leadership and Management, Kingston University, London, UK.
³ Economic Evaluation and HTA (EEHTA) CEIS, Faculty of Economics, University of Rome "Tor Vergata", Via Columbia 2, 00133, Rome, Italy. andrea.marcellusi@uniroma2.it.
⁴ Department of Demography, University of Rome "La Sapienza", Rome, Italy. andrea.marcellusi@uniroma2.it.
⁵ Center for Health Economics Research Hannover (CHERH), Leibniz Universität Hannover, Hannover, Germany.
⁶ Department of Public Health, Health Economics Research Centre, University of Oxford, Oxford, UK.
⁷ PSL, Université Paris-Dauphine, LEDa-LEGOS, 75016, Paris, France.
⁸ Market Access Deptartment, Daiichi Sankyo Europe, Munich, Germany.
⁹ Department of Economics and Business, CRES, Universitat Pompeu Fabra Barcelona, Barcelona, Spain.
¹⁰ Associazione Nazionale Medici Cardiologi Ospedalieri Research Center, Florence, Italy.
¹¹ Department of Nephrology and Hypertension, University Hospital Erlangen, Erlangen, Germany.

No abstract available

Comment on

Cost of poor adherence to anti-hypertensive therapy in five European countries.
Mennini FS, Marcellusi A, von der Schulenburg JM, Gray A, Levy P, Sciattella P, Soro M, Staffiero G, Zeidler J, Maggioni A, Schmieder RE. Mennini FS, et al. Eur J Health Econ. 2015 Jan;16(1):65-72. doi: 10.1007/s10198-013-0554-4. Epub 2014 Jan 5. Eur J Health Econ. 2015. PMID: 24390212
Commentary to: Cost of poor adherence to anti-hypertensive therapy in five European countries.
Gandjour A. Gandjour A. Eur J Health Econ. 2015 Nov;16(8):907. doi: 10.1007/s10198-015-0713-x. Eur J Health Econ. 2015. PMID: 26216671 No abstract available.